🔗 Share this article

Chancellor Reeves has announced she is preparing "targeted measures to tackle household expense challenges" in next month's Budget.

In comments to the BBC, she noted that lowering price rises is a shared duty of both the government and the central bank.

The UK's inflation rate is expected to be the most elevated among the G7 industrialized countries this calendar year and the following year.

Possible Utility Bill Interventions

Reports indicate the administration could take action to reduce energy bills, for instance by cutting the current 5% level of value-added tax charged on energy supplies.

An additional option is to lower some of the government charges presently included in bills.

Budgetary Limitations and Expert Predictions

The government will obtain the latest report from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for these measures.

The view from the majority of experts is that the Chancellor will have to announce tax increases or spending cuts in order to adhere to her declared borrowing rules.

Earlier on Thursday, analysis suggested there was a £22 billion deficit for the chancellor to resolve, which is at the lower end of expectations.

"There's a collective job between the Bank of England and the administration to continue tackling some of the drivers of price increases," Reeves told the BBC in Washington, at the yearly gatherings of the IMF and World Bank.

Revenue Pledges and International Concerns

While much of the focus has been on probable tax rises, the chancellor said the most recent figures from the fiscal watchdog had not changed her commitment to campaign commitments not to raise rates on earnings tax, VAT or National Insurance.

She blamed an "unpredictable global environment" with rising geopolitical and commercial tensions for the Budget tax moves, likely to be directed on those "wealthiest."

International Economic Tensions

Referring to apprehensions about the UK's commercial links with the Asian nation she said: "The UK's security interests always are paramount."

Recent statement by China to tighten trade restrictions on critical minerals and other materials that are essential for high-technology production led US President the US President to threaten an further 100% import tax on imports from the Asian country, increasing the prospect of an full-scale commercial conflict between the two global powers.

The American finance chief described the Chinese action "economic coercion" and "a global supply chain power grab."

Questioned on accepting the US offer to participate in its battle with China, Reeves said she was "extremely troubled" by China's actions and called on the Chinese government "to avoid restrictions and restrict access."

She said the action was "harmful for the international commerce and generates further headwinds."

"I believe there are sectors where we need to address China, but there are also important chances to trade with Chinese markets, including financial services and other areas of the economic system. We've got to maintain that balance right."

The chancellor also confirmed she was cooperating with other major economies "on our own essential resources strategy, so that we are reduced dependence."

Health Service Medicine Pricing and Investment

The Chancellor also acknowledged that the price the NHS spends on medicines could go up as a consequence of current negotiations with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and capital.

Some of the biggest global drug companies have said in recent statements that they are either halting or abandoning investments in the UK, with some blaming the insufficient payments they are receiving.

Recently, the Science Minister said the price the NHS spends on medicines would must rise to prevent firms and drug research funding departing from the UK.

Reeves stated to media: "We have seen as a result of the payment system, that drug testing, innovative medicines have not been provided in the UK in the extent that they are in other EU nations."

"The objective is to guarantee that patients getting treatment from the National Health Service are can receive the best essential drugs in the globe. And so we are looking at these issues, and... looking to obtain more funding into the UK."